Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017

Latest news articles

Added 2 months ago Drug news

FDA grants market authorization of ClearL Lab Reagents (T1, T2, B1, B2, M) to Beckman Coulter, aid in the detection of leukemias and lymphomas.

The FDA has granted market authorization of ClearLLab Reagents (T1, T2, B1, B2, M) to Beckman Coulter, Inc. The allowed...

Added 2 months ago Drug news

Phase III ECHELON-1 trial of Adcetris (brentuximab vedotin) met primary endpoint in untreated Hodgkin lymphoma- Takeda Pharmaceutical and Seattle Genetics

Takeda Pharmaceutical and Seattle Genetics announced that the Phase III ECHELON-1 clinical trial of Adcetris (brentuximab vedotin) in previously untreated...

Added 3 months ago Drug news

BMS and Seattle Genetics move Adcetris (brentuximab vedotin) and Opdivo (nivolumab) combination into Phase III forclassical Hodgkin lymphoma .

Bristol-Myers Squibb Company (BMS) and Seattle Genetics, Inc. announced that the companies have entered into a collaboration agreement to evaluate...

Search all news articles for Hodgkin's disease

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.


Hyperammonaemia can result in serious neurological damage or death. Could you recognise the signs and symptoms?

Visit Hyperammonaemia

Prostate Cancer

How can you balance the harmful effects of treatment with control of prostate cancer growth in otherwise healthy patients?

+ 1 more

Visit Prostate Cancer


Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma

The objective of this guideline is to provide healthcare professionals with guidance on the investigation and management of patients with...

Added 1 year ago

Guidelines on the management and admission to intensive care of critically ill adult patients with haematological malignancy in the UK

This guideline is intended to be of use to haematologists and intensivists practising in the UK, and outlines some of...

Added 1 year ago

Hodgkin's Lymphoma: ESMO Clinical Practice Guidelines

The 2014 update elaborates on two histologically distinguished entities: classical Hodgkin's lymphoma that accounts about 95% of cases and nodular lymphocyte-predominant Hodgkin's lymphoma...

Added 11 months ago

Search all guidelines for Hodgkin's disease

Journal articles

Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents.

Despite the success of anti-CD20 monoclonal antibody (mAb) in the treatment of lymphoma, there remains considerable uncertainty about their mechanism(s) of action.

Added 3 months ago

Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection.

Rituximab, a monoclonal antibody that targets CD20 on B cells, is now central to the treatment of a variety of malignant and autoimmune disorders.

Added 3 months ago

Search all journal articles for Hodgkin's disease

Clinical trials

A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma

This is a single-arm, open-label, multicenter, pivotal clinical trial to evaluate the efficacy and safety of brentuximab vedotin (SGN-35) as...

Added 9 years ago

A Dose-Escalating Study of Obinutuzumab in Patients With B-lymphocyte Antigen (CD20+) Malignant Disease (GAUGUIN)

The primary objective for the phase I part of the study is to investigate the safety and tolerability of escalating intravenous (IV) doses of obinutuzumab given as monotherapy...

Added 5 months ago

Search all clinical trials for Hodgkin's disease
Fiona Holland

Fiona worked in the fitness and wellness industry in the US for 13 years, supporting behaviour change in a variety of settings. Fiona’s research interests lie broadly within health and wellbeing. She is particularly interested in qualitative methodologies in the areas of body image ... Read more

What to say and do when someone has cancer

Ahead of World Cancer Day on Saturday (February 4), Fiona Holland, Psychology Lecturer, discusses what to say and what not to say to someone with cancer.